High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context

Background: Despite promising treatments for breast cancer, mortality rates remain high and treatments for metastatic disease are limited. High-frequency irreversible electroporation (H-FIRE) is a novel tumor ablation technique that utilizes high-frequency bipolar electric pulses to destabilize canc...

Full description

Bibliographic Details
Main Authors: Veronica M. Ringel-Scaia, Natalie Beitel-White, Melvin F. Lorenzo, Rebecca M. Brock, Kathleen E. Huie, Sheryl Coutermarsh-Ott, Kristin Eden, Dylan K. McDaniel, Scott S. Verbridge, John H. Rossmeisl, Jr, Kenneth J. Oestreich, Rafael V. Davalos, Irving C. Allen
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396419303445
id doaj-8cdf471392134f86aabad70896d0c9d6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Veronica M. Ringel-Scaia
Natalie Beitel-White
Melvin F. Lorenzo
Rebecca M. Brock
Kathleen E. Huie
Sheryl Coutermarsh-Ott
Kristin Eden
Dylan K. McDaniel
Scott S. Verbridge
John H. Rossmeisl, Jr
Kenneth J. Oestreich
Rafael V. Davalos
Irving C. Allen
spellingShingle Veronica M. Ringel-Scaia
Natalie Beitel-White
Melvin F. Lorenzo
Rebecca M. Brock
Kathleen E. Huie
Sheryl Coutermarsh-Ott
Kristin Eden
Dylan K. McDaniel
Scott S. Verbridge
John H. Rossmeisl, Jr
Kenneth J. Oestreich
Rafael V. Davalos
Irving C. Allen
High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context
EBioMedicine
author_facet Veronica M. Ringel-Scaia
Natalie Beitel-White
Melvin F. Lorenzo
Rebecca M. Brock
Kathleen E. Huie
Sheryl Coutermarsh-Ott
Kristin Eden
Dylan K. McDaniel
Scott S. Verbridge
John H. Rossmeisl, Jr
Kenneth J. Oestreich
Rafael V. Davalos
Irving C. Allen
author_sort Veronica M. Ringel-Scaia
title High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context
title_short High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context
title_full High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context
title_fullStr High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context
title_full_unstemmed High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context
title_sort high-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityresearch in context
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2019-06-01
description Background: Despite promising treatments for breast cancer, mortality rates remain high and treatments for metastatic disease are limited. High-frequency irreversible electroporation (H-FIRE) is a novel tumor ablation technique that utilizes high-frequency bipolar electric pulses to destabilize cancer cell membranes and induce cell death. However, there is currently a paucity of data pertaining to immune system activation following H-FIRE and other electroporation based tumor ablation techniques. Methods: Here, we utilized the mouse 4T1 mammary tumor model to evaluate H-FIRE treatment parameters on cancer progression and immune system activation in vitro and in vivo. Findings: H-FIRE effectively ablates the primary tumor and induces a pro-inflammatory shift in the tumor microenvironment. We further show that local treatment with H-FIRE significantly reduces 4T1 metastases. H-FIRE kills 4T1 cells through non-thermal mechanisms associated with necrosis and pyroptosis resulting in damage associated molecular pattern signaling in vitro and in vivo. Our data indicate that the level of tumor ablation correlates with increased activation of cellular immunity. Likewise, we show that the decrease in metastatic lesions is dependent on the intact immune system and H-FIRE generates 4T1 neoantigens that engage the adaptive immune system to significantly attenuate tumor progression. Interpretation: Cell death and tumor ablation following H-FIRE treatment activates the local innate immune system, which shifts the tumor microenvironment from an anti-inflammatory state to a pro-inflammatory state. The non-thermal damage to the cancer cells and increased innate immune system stimulation improves antigen presentation, resulting in the engagement of the adaptive immune system and improved systemic anti-tumor immunity. Keywords: IRE, Breast cancer, Metastasis, Tumor microenvironment, Pyroptosis
url http://www.sciencedirect.com/science/article/pii/S2352396419303445
work_keys_str_mv AT veronicamringelscaia highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT nataliebeitelwhite highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT melvinflorenzo highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT rebeccambrock highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT kathleenehuie highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT sherylcoutermarshott highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT kristineden highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT dylankmcdaniel highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT scottsverbridge highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT johnhrossmeisljr highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT kennethjoestreich highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT rafaelvdavalos highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
AT irvingcallen highfrequencyirreversibleelectroporationisaneffectivetumorablationstrategythatinducesimmunologiccelldeathandpromotessystemicantitumorimmunityresearchincontext
_version_ 1725083660191793152
spelling doaj-8cdf471392134f86aabad70896d0c9d62020-11-25T01:32:02ZengElsevierEBioMedicine2352-39642019-06-0144112125High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in contextVeronica M. Ringel-Scaia0Natalie Beitel-White1Melvin F. Lorenzo2Rebecca M. Brock3Kathleen E. Huie4Sheryl Coutermarsh-Ott5Kristin Eden6Dylan K. McDaniel7Scott S. Verbridge8John H. Rossmeisl, Jr9Kenneth J. Oestreich10Rafael V. Davalos11Irving C. Allen12Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USABioelectromechanical Systems Laboratory, Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA; Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USABioelectromechanical Systems Laboratory, Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA; Virginia Tech - Wake Forest University, Virginia Tech, School of Biomedical Engineering & Sciences, Blacksburg, VA, USAGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USADepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USADepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USADepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USA; Department of Basic Science Education, Virginia Tech Carilion School of Medicine, Roanoke, VA, USADepartment of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USAVirginia Tech - Wake Forest University, Virginia Tech, School of Biomedical Engineering & Sciences, Blacksburg, VA, USA; Center for Engineered Health, Virginia Tech, Institute for Critical Technology and Applied Science, Blacksburg, VA, USACenter for Engineered Health, Virginia Tech, Institute for Critical Technology and Applied Science, Blacksburg, VA, USA; Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USAGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USA; Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Center for Engineered Health, Virginia Tech, Institute for Critical Technology and Applied Science, Blacksburg, VA, USA; Virginia Tech, Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, USAGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA; Bioelectromechanical Systems Laboratory, Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA; Virginia Tech - Wake Forest University, Virginia Tech, School of Biomedical Engineering & Sciences, Blacksburg, VA, USA; Department of Basic Science Education, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Center for Engineered Health, Virginia Tech, Institute for Critical Technology and Applied Science, Blacksburg, VA, USAGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, USA; Department of Basic Science Education, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Center for Engineered Health, Virginia Tech, Institute for Critical Technology and Applied Science, Blacksburg, VA, USA; Corresponding author at: Department of Biomedical Sciences and Pathobiology, Virginia Tech, Virginia Maryland College of Veterinary Medicine, 295 Duckpond Drive, Blacksburg, VA 24061, USA.Background: Despite promising treatments for breast cancer, mortality rates remain high and treatments for metastatic disease are limited. High-frequency irreversible electroporation (H-FIRE) is a novel tumor ablation technique that utilizes high-frequency bipolar electric pulses to destabilize cancer cell membranes and induce cell death. However, there is currently a paucity of data pertaining to immune system activation following H-FIRE and other electroporation based tumor ablation techniques. Methods: Here, we utilized the mouse 4T1 mammary tumor model to evaluate H-FIRE treatment parameters on cancer progression and immune system activation in vitro and in vivo. Findings: H-FIRE effectively ablates the primary tumor and induces a pro-inflammatory shift in the tumor microenvironment. We further show that local treatment with H-FIRE significantly reduces 4T1 metastases. H-FIRE kills 4T1 cells through non-thermal mechanisms associated with necrosis and pyroptosis resulting in damage associated molecular pattern signaling in vitro and in vivo. Our data indicate that the level of tumor ablation correlates with increased activation of cellular immunity. Likewise, we show that the decrease in metastatic lesions is dependent on the intact immune system and H-FIRE generates 4T1 neoantigens that engage the adaptive immune system to significantly attenuate tumor progression. Interpretation: Cell death and tumor ablation following H-FIRE treatment activates the local innate immune system, which shifts the tumor microenvironment from an anti-inflammatory state to a pro-inflammatory state. The non-thermal damage to the cancer cells and increased innate immune system stimulation improves antigen presentation, resulting in the engagement of the adaptive immune system and improved systemic anti-tumor immunity. Keywords: IRE, Breast cancer, Metastasis, Tumor microenvironment, Pyroptosishttp://www.sciencedirect.com/science/article/pii/S2352396419303445